acquire – Modcanyon

Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B

October 9, 2023

Bristol-Myers Squibb to acquire Mirati Therapeutics for .8B

Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. Bristol-Myers (BMY) agreed to acquire

Business Plan

Integra to obtain Surgical Innovation; plans $150M inventory buyback program

December 1, 2022 Antoni Gaudi

Integra to obtain Surgical Innovation; plans 0M inventory buyback program

pichet_w Integra LifeSciences (NASDAQ:IART) is obtaining Surgical Innovation Buddies (SIA) to reinforce its plastic and reconstructive surgical operation portfolio. SIA develops and sells DuraSorb, a

Tag: acquire

Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B

Integra to obtain Surgical Innovation; plans $150M inventory buyback program